Innate allorecognition induces HSP70 in monocytes contributing to renal allograft rejection
JCI Insight · 2026
DOI: 10.1172/jci.insight.197348 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Zeping Gui und 13 weiteren Autor:innen. Beteiligte Einrichtung: Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine and University of Pittsburgh Medical C…. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, HSP70 Heat-Shock Proteins, Monocytes. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH.
Abstract (Originalsprache)
After encountering allogeneic nonself, monocytes differentiate to DCs, which in turn activate the adaptive immune system that drives transplant rejection. The downstream mechanisms of allorecognition are largely unknown. We analyzed scRNA-seq data sets to identify transcriptional changes in monocytes occurring after allostimulation. Hspa1a , which encodes HSP70, was upregulated in monocytes after allostimulation in contrast to syngeneic controls in mice lacking T, B, and NK cells. Similar findings were seen in scRNA-seq data derived from kidney biopsies of rejecting transplant patients. To validate the role of HSP70 in innate allorecognition and transplantation, we performed allogeneic bone marrow plug and kidney transplantation into WT, Hspa1a/Hspa1b –/– , and DSG-treated (HSP70 inhibitor) B6 mice and examined the graft immune infiltrate. Histology, T cell infiltration, and survival were assessed in kidney transplanted mice. In both models, DSG-treated or HSP70-KO recipients displayed significantly reduced infiltration by monocyte-derived DCs (mo-DC). Chronic rejection of Balb/c kidney grafts in WT B6 recipients was attenuated in DSG-treated and HSP70-KO recipients as indicated by a reduction in Banff score. Further experiments demonstrated that in vitro allostimulated immature HSP70-KO BMDC showed less maturation compared with WT BMDC. Targeting HSP70 in innate immune cells offers a novel approach to reduce chronic kidney graft rejection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Division of Transplant Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Förderung
- NIAID NIH HHS
- NIH
Zitieren
APA
Gui, Z., Feizi, N., Demirors, B., Lin, C., Dai, H., Al Moussawy, M., Friday, A., Sanders, S. M., Halesha, L., Williams, A. L., Sacirbegovic, F., Randhawa, P. S., Abou-Daya, K. I., & Oberbarnscheidt, M. H. (2026). Innate allorecognition induces HSP70 in monocytes contributing to renal allograft rejection. JCI Insight. https://doi.org/10.1172/jci.insight.197348
Vancouver
Gui Z, Feizi N, Demirors B, Lin C, Dai H, Al Moussawy M, et al. Innate allorecognition induces HSP70 in monocytes contributing to renal allograft rejection. JCI Insight. 2026. doi:10.1172/jci.insight.197348
BibTeX
@article{Gui2026,
author = {Gui, Zeping and Feizi, Neda and Demirors, Berkay and Lin, Canxiang and Dai, Hehua and Al Moussawy, Mouhamad and Friday, Andrew and Sanders, Steven M and Halesha, Latha and Williams, Amanda L and Sacirbegovic, Faruk and Randhawa, Parmjeet S and Abou-Daya, Khodor I and Oberbarnscheidt, Martin H},
title = {Innate allorecognition induces HSP70 in monocytes contributing to renal allograft rejection},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.197348}
}
EUVIMED